ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth
ZNF207 stabilizes the glutamine transporter ASCT2 by blocking SPOP-driven ubiquitin-proteasome degradation, sustaining AKT/mTORC1 signaling in hepatocellular carcinoma cells.










